The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma
Chao Qin(Jiangsu Province Hospital), Changjun Yin(Sun Yat-sen University), Qing Zou(Tang Du Hospital), Li Cui(Soochow University), Haiyan Chu(Nanjing Medical University), Minjun Jiang(Wujiang District People's Hospital), Jian Wang(Wenzhou Medical University), Hu Zhao(Fuzhou General Hospital of Nanjing Military Command), Xuesong Li(Peking University), Pu Li(Jiangsu Province Hospital), Zhengdong Zhang(Nanjing Medical University), Xiaoxiang Wang, Hailiang Zhang(Sun Yat-sen University), Liqun Zhou(Peking University), Lijiang Sun(Qingdao University), Xiaobing Ju(Jiangsu Province Hospital), Jianchun Chen(Vanderbilt Health), Pengfei Shao(Jiangsu Province Hospital), Bin Wu(ShenZhen People’s Hospital), Shangqian Wang(Memorial Sloan Kettering Cancer Center), Jian Zhu(Anyang Hospital of Traditional Chinese Medicine), Dingwei Ye(Fudan University), Meilin Wang(Xiamen University), Qiang Cao(Kunming University of Science and Technology), Yong Huang(Shenyang Jianzhu University), Baijun Dong(Shanghai Jiao Tong University), Hai Zhou(Yuncheng University), Fade Liu(Nanjing Jiangning Hospital), Junbiao Ji(Nanjing Jiangning Hospital), Hongzhou Cai(Jiangsu Province Hospital)
Cited by 31
Related Papers
Regulation of cellular iron metabolism
|Biochemical Journal|2011|964
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
Inhibition of neuronal ferroptosis protects hemorrhagic brain
|JCI Insight|2017|702
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471